Why Cigna Denies Biologic Therapy (Autoimmune)
Step therapy not completed (conventional DMARDs first)
Prior biologic trial not documented
Biosimilar required before brand-name biologic
Know Cigna / Evernorth's Criteria
Cigna uses their own Coverage Policies and InterQual criteria. Medical directors are generally accessible for P2P review.
Key policies to know:
- Coverage Policies available on cigna.com/coverage-policies
- Uses eviCore for specialty benefits management
- Known for step therapy requirements on specialty drugs
- Collaborative care approach with emphasis on outcomes data
Cigna's Specific Approach to Biologic Therapy (Autoimmune)
Applicable Policy
Cigna Coverage Policy IP0345 (varies by biologic class)
How Cigna Typically Denies This
Cigna has been aggressive about biosimilar-first policies and may require a trial of biosimilar before the reference biologic. They also require documentation that the prescriber is an appropriate specialist.
Your Strategy for This Payer
Cigna tends to be reasonable on biologics if the documentation is there. Focus on disease burden, failed conventional therapy, and specialist management. If they're pushing biosimilar, acknowledge willingness unless there's a clinical contraindication.
Key Phrase to Use on the Call
"As the treating [rheumatologist/gastroenterologist/dermatologist], I've determined that [specific biologic] is the most appropriate choice based on [disease-specific factors] after failure of [conventional therapy]."
Building Your Medical Necessity Argument
Document failure, intolerance, or contraindication to step therapy agents
Note disease activity scores (DAS28, CDAI, PASI)
If biosimilar switch requested, document clinical reason for brand
Reference comorbidities that limit alternative treatments
P2P Call Tips for Cigna
Reference Cigna Coverage Policy by number
Cigna medical directors tend to be collaborative -- frame it as shared decision-making
Emphasize outcomes data and evidence-based medicine
Be prepared to discuss alternatives and why they were insufficient
Guidelines to Reference
- ACR Guidelines for Rheumatoid Arthritis Treatment
- AGA Guidelines for Biologic Therapy in IBD
- AAD Guidelines for Biologic Therapy in Psoriasis
Relevant CPT Codes
Specialty: Rheumatology / Gastroenterology / Dermatology
Want the full strategy?
The P2P Playbook covers payer-specific approaches for Biologic Therapy (Autoimmune) denied by Cigna -- plus 15 denial objections with word-for-word responses, what reviewers are actually thinking, and the 60-second prep framework. Written by a medical director who reviewed cases for major payers.
Get The P2P Playbook -- $39Get a personalized P2P script in 60 seconds
Enter your specific case details and our AI generates a structured prep script tailored to Cigna's criteria.